Clinical Trial Detail

NCT ID NCT01609816
Title Dasatinib in Treating Patients With Multiple Myeloma, Non-Hodgkin, or Hodgkin Lymphoma Previously Treated With Autologous Stem Cell Transplant
Recruitment Active, not recruiting
Gender both
Phase Phase Ib/II
Variant Requirements no
Sponsors Barbara Ann Karmanos Cancer Institute
Indications

Hodgkin's lymphoma

multiple myeloma

non-Hodgkin lymphoma

Therapies

Dasatinib

Age Groups: adult

No variant requirements are available.